Picture of Whitehawk Therapeutics logo

WHWK — Whitehawk Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

Brief: Aadi Bioscience Q1 product sales USD 5.867 million

May 10 (Reuters) - Aadi Bioscience Q1 operating income USD -16.825 million.
* Q1 operating expenses USD 22.692 million
* Q1 product sales USD 5.867 million
* Q1 net income USD -15.223 million

Recent news on Whitehawk Therapeutics

See all news